Skip to main content
Clinical Trials/NCT05869084
NCT05869084
Completed
Not Applicable

Assessment of Bronchial Obstruction in Adolescents With HIV

Assistance Publique - Hôpitaux de Paris1 site in 1 country21 target enrollmentMarch 1, 2022
ConditionsHIV

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
21
Locations
1
Primary Endpoint
Resistance measured by forced oscillometry (5hZ)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In children, data from the literature find a higher prevalence of asthma in the population treated for HIV. Bronchial hyperreactivity, indicative of chronic inflammation and bronchial obstruction, is also present.

Screening for early peripheral obstruction could therefore make it possible to initiate appropriate anti-inflammatory treatment, if necessary, and early preventive management.

Detailed Description

In adults chronically infected with HIV, there is an increased prevalence impaired respiratory function, with a greater occurrence of COPD than in the uninfected population. In children, data from the literature find a prevalence of greater atopy in the HIV-infected pediatric population. Furthermore, a bronchial hyperreactivity or even peripheral bronchial obstruction, indicative of a local chronic inflammation has been found in young adolescents treated since the birth for HIV infection in utero. Screening for early peripheral obstruction in HIV-infected adolescents could therefore make it possible to initiate, if necessary, a anti-inflammatory treatment, and early management to prevent the occurrence of impaired respiratory function in adulthood For this this single-center prospective study chose to perform respiratory function explorations with forced oscillometry with the Endpoint main factor of the peripheral obstruction the R5HZ parameter expressed in % predicted. Patients from 11 to 25 years to whom it was proposed added to that to answer a questionnaire of respiratory quality of life

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
July 1, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children over 11 and Under 25-year-old infected with HIV and on antiretrovirals and followed up at Robert Debré hospital for this pathology
  • Consent of the holders of parental authority and Patients informed and not objecting to participate in research Exclusion Criteria : •
  • Age ≤ 11 years old
  • Not treated for HIV
  • Patients under guardianship / curatorship

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Resistance measured by forced oscillometry (5hZ)

Time Frame: 24 hours

Resistance measured by forced oscillometry (5hZ)

Study Sites (1)

Loading locations...

Similar Trials